These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23686154)

  • 1. Further support for five dimensions of obsessive-compulsive symptoms.
    Brakoulias V; Starcevic V; Berle D; Sammut P; Milicevic D; Moses K; Hannan A; Martin A
    J Nerv Ment Dis; 2013 Jun; 201(6):452-9. PubMed ID: 23686154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The characteristics of unacceptable/taboo thoughts in obsessive-compulsive disorder.
    Brakoulias V; Starcevic V; Berle D; Milicevic D; Moses K; Hannan A; Sammut P; Martin A
    Compr Psychiatry; 2013 Oct; 54(7):750-7. PubMed ID: 23587527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist.
    Storch EA; Larson MJ; Price LH; Rasmussen SA; Murphy TK; Goodman WK
    J Anxiety Disord; 2010 Aug; 24(6):650-6. PubMed ID: 20471199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Washing, checking, and rumination: are the belief domains, obsessions and compulsions specific to OCD subtypes?].
    Kaiser B; Bouvard M; Milliery M
    Encephale; 2010 Feb; 36(1):54-61. PubMed ID: 20159197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family accommodation in obsessive-compulsive disorder: Relation to symptom dimensions, clinical and family characteristics.
    Albert U; Bogetto F; Maina G; Saracco P; Brunatto C; Mataix-Cols D
    Psychiatry Res; 2010 Sep; 179(2):204-11. PubMed ID: 20483467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
    Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
    J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceived parental rearing style in obsessive-compulsive disorder: relation to symptom dimensions.
    Alonso P; Menchón JM; Mataix-Cols D; Pifarré J; Urretavizcaya M; Crespo JM; Jiménez S; Vallejo G; Vallejo J
    Psychiatry Res; 2004 Jul; 127(3):267-78. PubMed ID: 15296826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical predictors of health-related quality of life in obsessive-compulsive disorder.
    Albert U; Maina G; Bogetto F; Chiarle A; Mataix-Cols D
    Compr Psychiatry; 2010; 51(2):193-200. PubMed ID: 20152302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist.
    Sulkowski ML; Storch EA; Geffken GR; Ricketts E; Murphy TK; Goodman WK
    J Clin Psychol; 2008 Dec; 64(12):1338-51. PubMed ID: 18942133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The familiality of specific symptoms of obsessive-compulsive disorder.
    Brakoulias V; Starcevic V; Martin A; Berle D; Milicevic D; Viswasam K
    Psychiatry Res; 2016 May; 239():315-9. PubMed ID: 27058157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
    Rosario-Campos MC; Miguel EC; Quatrano S; Chacon P; Ferrao Y; Findley D; Katsovich L; Scahill L; King RA; Woody SR; Tolin D; Hollander E; Kano Y; Leckman JF
    Mol Psychiatry; 2006 May; 11(5):495-504. PubMed ID: 16432526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Yale-Brown Obsessive Compulsive Scale (YBOCS-hd) for heavy drinking with mild to moderately dependent alcohol abusers.
    Fedoroff I; Sobell LC; Agrawal S; Sobell MB; Gavin DR
    Alcohol Clin Exp Res; 1999 Sep; 23(9):1477-83. PubMed ID: 10512313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationships between obsessive-compulsive symptom dimensions and cognitions in obsessive-compulsive disorder.
    Brakoulias V; Starcevic V; Berle D; Milicevic D; Hannan A; Martin A
    Psychiatr Q; 2014 Jun; 85(2):133-42. PubMed ID: 24142072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obsessive-compulsive symptom dimensions in schizophrenia patients with comorbid obsessive-compulsive disorder.
    Faragian S; Pashinian A; Fuchs C; Poyurovsky M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1009-12. PubMed ID: 19447155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further development of YBOCS dimensions in the OCD Collaborative Genetics study: symptoms vs. categories.
    Pinto A; Greenberg BD; Grados MA; Bienvenu OJ; Samuels JF; Murphy DL; Hasler G; Stout RL; Rauch SL; Shugart YY; Pauls DL; Knowles JA; Fyer AJ; McCracken JT; Piacentini J; Wang Y; Willour VL; Cullen B; Liang KY; Hoehn-Saric R; Riddle MA; Rasmussen SA; Nestadt G
    Psychiatry Res; 2008 Jul; 160(1):83-93. PubMed ID: 18514325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern typology of symptoms and obsessive-compulsive syndromes: results of a large French study of 615 patients].
    Hantouche EG; Lancrenon S
    Encephale; 1996 May; 22 Spec No 1():9-21. PubMed ID: 8767023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hungarian translation of the Dimensional Yale-Brown Obsessive-Compulsive Scale and our first experiences with the test].
    Harsányi A; Csigó K; Demeter G; Rajnai C; Németh A; Racsmány M
    Psychiatr Hung; 2009; 24(1):18-59. PubMed ID: 19542567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in obsessive-compulsive symptom dimensions.
    Labad J; Menchon JM; Alonso P; Segalas C; Jimenez S; Jaurrieta N; Leckman JF; Vallejo J
    Depress Anxiety; 2008; 25(10):832-8. PubMed ID: 17436312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of psychotropic agents for the symptoms of obsessive-compulsive disorder.
    Brakoulias V; Starcevic V; Berle D; Milicevic D; Moses K; Hannan A; Sammut P; Martin A
    Australas Psychiatry; 2013 Apr; 21(2):117-21. PubMed ID: 23426097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.